Top Markets
Coin of the day
Hansa Biopharma AB Hansa Biopharma AB

Hansa Biopharma AB

HNSBF
Rangering i aksjer #15161
Hansa Biopharma AB (publ), a biopharmaceutical company, engages in development... Hansa Biopharma AB (publ), a biopharmaceutical company, engages in development and commercialization of treatments for patients with rare immunological conditions in Sweden, North America, and rest of Europe. The company offers Idefirix(imlifidase), which targets and cleaves all classes of immunoglobulin G (IgG) antibodies for the desensitization treatment of sensitized adult kidney transplant patients with a positive crossmatch test. It is also developing HNSA-5487, a next generation IgG-cleaving enzyme to address acute and chronic neuro-autoimmune conditions, including myasthenia gravis. In addition, the company evaluates imlifidase in three therapy areas, including autoimmune, gene therapy, and transplantation. It has a collaboration agreement with Sarepta Therapeutics to assess imlifidase as a pre-treatment in limb-girdle muscular dystrophy (LGMD) and duchenne muscular dystrophy (DMD); AskBio to evaluate imlifidase as a pre-treatment in pompe disease; and research and development collaboration agreement with Genethon to evaluate the safety and efficacy of imlifidase as pre-treatment to gene therapy in Crigler-Najjar syndrome patients with anti-AAV antibodies. Hansa Biopharma AB (publ) was incorporated in 2007 and is headquartered in Lund, Sweden.
Aksjekurs
$3.70
Sist synkronisert: 2026-08-28
Markedsverdi
$369.01M
Endring (1 dag)
0.00%
Endring (1 år)
35.04%
Land
SE
Handel Hansa Biopharma AB (HNSBF)

Kategori

Aksjeprishistorikk for Hansa Biopharma AB (HNSBF)
Høyeste sluttskurs: $3.70 den 2026-08-01

Laveste sluttskurs: $4.71 den 2015-03-01
Aksjeprishistorikk for Hansa Biopharma AB fra 2015 til 2026
Årlig aksjeprisytelse
År Ytelse
2026 (TTM) 7.87%
2025 -0.21%
2024 29.03%
2023 -54.16%
2022 -51.64%
2021 -65.44%
2020 200.34%
2019 -69.02%
2018 10.98%
2017 118.54%
2016 302.77%
2015 0.00%
Aksjepris for lignende selskaper eller konkurrenter
Selskap Aksjepris Endring 1år% Land
$61.61 71.22%
US
$51.09 69.52%
SE
$194.53 42.09%
FR
$62.45 0.05%
IT
$113.45 62.73%
US